DNA services/adaptive biotechnologies/zacharakis
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201800037P
- Awardee
-
Adaptive Biotechnologies Corporation UEI DMW5BNQ331K9
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,550
Award facts
- Contract value 100% obligated
- $3,550.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Piscataway, NJ 08854, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Adaptive Biotechnologies Corporation for $3,550.00 on November 14, 2017, with ultimate completion on December 14, 2017. Place of performance is Piscataway, New Jersey. The order procures DNA services under firm fixed-price terms without set-aside designation.
Quick answers
Who was awarded contract HHSN261201800037P?
HHSN261201800037P was awarded to Adaptive Biotechnologies Corporation by National Cancer Institute (National Institutes of Health) on November 14, 2017.
How much is contract HHSN261201800037P worth?
The government has obligated $3,550 on HHSN261201800037P.
Was contract HHSN261201800037P competed?
The extent of competition for HHSN261201800037P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award